Eden Research plc, a company focused on sustainable biopesticides and plastic-free formulation technology, has granted options under its Long-Term Incentive Plan (LTIP) to its Chief Executive Officer, Sean Smith, and Chief Finance Officer, Alex Abrey. The grant consists of options over 8,698,909 new Ordinary Shares in Eden, with a strike price of 5.05p each. Smith has been awarded 4,968,000 options, while Abrey has been awarded 3,730,909 options. The options will expire on August 31, 2027, and will vest in three equal tranches over a period of 24 months from the date of grant.

In addition, the Board has agreed to extend the exercise date for 3,500,000 options granted to Smith and Abrey in April 2021 under the LTIP. The options, which have a strike price of 6p, were originally due to expire on June 30, 2023, but will now expire on December 31, 2023. The extension was granted due to the unusually long closed period that the Executives were placed in prior to the options' expiration date.

The company's contact information is provided for further information. Cenkos Securities plc is the nominated advisor and broker for Eden Research, while Hawthorn Advisors is the company's financial PR firm.

The news includes notifications made in accordance with the requirements of the EU Market Abuse Regulation, providing details of the individuals involved in the transactions and the nature of the transactions.